Results 141 to 150 of about 59,368 (237)

Comparing the effectiveness and safety of rescue balloon angioplasty versus stenting in acute large vessel occlusion after thrombectomy. [PDF]

Stroke Vasc Neurol
Jiang Y, Li C, Shi M, Song K, Cong M, Zhang W, Li L, Wang S.   +7 more
europepmc   +1 more source

Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State [PDF]

A puzzling feature of many medical innovations is that they simultaneously appear to reduce unit costs and increase total costs. We consider this phenomenon by examining the diffusion of percutaneous transluminal coronary angioplasty (PTCA) -- a ...
David M. Cutler, Robert S. Huckman
core  

Predictors of target lesion revascularization after paclitaxel-coated balloon angioplasty for <i>de novo</i> coronary artery lesions. [PDF]

Front Cardiovasc Med
Suharjo T, Saboe A, Wahyudi DP, Yahya AF.   +3 more
europepmc   +1 more source

Comparison of drug-coated balloons and plain old balloon angioplasty in hemodialysis patients with Below-The-Knee artery disease. [PDF]

Diab Vasc Dis Res
Jin ZY, Li CM, Ma LB, Wen JH, Ren HL, Wang SX.   +5 more
europepmc   +1 more source

Predictors of restenosis after drug-coated balloon angioplasty for femoropopliteal chronic total occlusion lesions. [PDF]

CVIR Endovasc
Shima Y, Sato M, Bando G, Irie N, Mushiake K, Inoue N, Tanaka H, Kadota K.   +7 more
europepmc   +1 more source

Advancing the Design of Observational Studies in Drug-Coated Balloon Angioplasty: Bridging Practice With Evidence-Based Standards. [PDF]

Clin Cardiol
Mahajan K, Sharma J, Himral S, Rana V, Vohra S.   +4 more
europepmc   +1 more source

Paclitaxel Drug-Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A US Single-Center Experience With the AGENT Balloon. [PDF]

Stroke Vasc Interv Neurol
Chaudhari A, Rosenstein ZM, Kamal R, Khan N, Almajali M, Ramirez-Abreu D, Al-Ghetaa JK, Ashouri Y, Lin E, Zaidat OO.   +9 more
europepmc   +1 more source

A Parameterized Cross-Sectional Model for Simulating Balloon Angioplasty in Atherosclerotic Arteries. [PDF]

Int J Numer Method Biomed Eng
Kwakman SMB, Terzano M, Rolf M, Holzapfel GA.   +3 more
europepmc   +1 more source

Value-based approach to AVF maintenance: institutional micro-costing of drug-coated versus plain balloon angioplasty in a fixed-reimbursement system. [PDF]

CVIR Endovasc
Lučev J, Dinevski D, Ekart R, Breznik S.   +3 more
europepmc   +1 more source

Long-Term Efficacy of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent for De Novo Large-Vessel Coronary Arteries. [PDF]

Circ Rep
Masuda M, Yamamoto H, Nakano S, Takahashi N, Miyata T, Inoue T, Takaya T.   +6 more
europepmc   +1 more source